About CJC-1295 Ipamorelin Coverage at CJC-Ipa Research

What this project is

CJC-Ipa Research is an independent editorial project that publishes plain-English summaries of the peer-reviewed research literature on CJC-1295 and ipamorelin. We read the studies, log the measured quantities — the GH fold-rise, the IGF-1 duration, the half-life split between the DAC and no-DAC forms, the selectivity data — and present them in a data-forward register with every figure cited to its source.

We are not a clinic. We do not employ clinicians and we do not provide medical advice. We do not manufacture, sell, or distribute any product. Our work is editorial commentary on publicly available science.

What the name means

The "research" in this site's framing is a position we occupy relative to the literature — a reading desk for the published record — not a claim that we conduct studies, run a laboratory, or offer research services. We summarize others' research; we do not perform it. There is no physical address, no phone line, and no clinical team behind this site. The data-forward instrument styling is an editorial choice that matches a subject built almost entirely on measured numbers, not a suggestion that we generate those numbers ourselves.

How we handle accuracy

Every quantitative claim on this site traces to a study in the references list, and the inline [N] markers let any reader check the source. We keep two lines visible at all times: the difference between what was measured in a study and what users report as anecdote, and the difference between the single-component data and the fixed CJC-1295 + ipamorelin blend, which has never been tested in a controlled trial. We do not state combination claims as proven, we do not provide human dosing, and we use only generic compound names — never drug brand names.

Status and scope

Neither CJC-1295 nor ipamorelin is approved by the FDA or any regulatory authority for human use; both are sold only as research chemicals, and both are prohibited at all times in sport under WADA Section S2. This site covers the science and the reported experience around these peptides for general readers. It is not a substitute for a qualified clinician, and nothing here should be read as a recommendation to obtain or use either compound.